01 / Contract Profile
HHSO100201700013C Federal Contract Award
Agency code 7505
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE KEY PERSONNEL UNDER SECTION G CONTRACT ADMINISTRATION ARTICLE G.4 KEY PERSONNEL TO INCLUDE JOHNNIE LEAD AS CLINICAL LEAD.
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
HHSO100201700013C contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$0
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2017 | $44.66M | 1 | — |
| FY 2018 | $78.45M | 1 | +75.7% |
| FY 2020 | $2.23M | 1 | −97.2% |
| FY 2021 | $6.95M | 1 | +212.1% |
| FY 2022 | $0 | 2 | −100.0% |
| FY 2023 | $0 | 1 | — |
| FY 2024 | $0 | 2 | — |
| FY 2025 | $0 | 1 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
JANSSEN VACCINES & PREVENTION B.V.
UEI VRE2EKNJTJJ4 · CAGE H1N64
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $132.28M | 10 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 6505 | DRUGS AND BIOLOGICALS | $132.28M | 10 | 100.0% |
08 / Place of Performance
Where is the work recorded?
NETHERLANDS
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Jan 22, 2025 | P00009 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Oct 8, 2024 | P00008 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Mar 7, 2024 | P00007 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Sep 14, 2023 | P00006 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Jun 23, 2022 | P00005 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Apr 8, 2022 | P00004 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Mar 5, 2021 | P00003 | $6.95M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Apr 6, 2020 | P00002 | $2.23M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Jul 25, 2018 | 1 | $78.45M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
| Sep 28, 2017 | Base action | $44.66M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | 6505 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.